Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Halil Degertekin"'
Autor:
Gulbanu Erkan, Irmak Sayin, Fatma Betül Polat, Gökçe Kaan Ataç, Halil Degertekin, Ahmet Corakci
Publikováno v:
The Turkish Journal of Gastroenterology. 25:63-68
Background/Aims: Nonalcoholic fatty liver disease is related to obesity, metabolic syndrome, and insulin resistance. Nonalcoholic fatty liver disease and metabolic syndrome may also be encountered in non-obese, non-diabetic individuals, and there are
Publikováno v:
Electronic Journal of General Medicine. 1:15-18
Liver cirrhosis is a severe disease with complications and viruses take the first place in the etiology of cirrhosis. In this study, the effects of liver cirrhosis due to viral hepatitis cardiac ventricular functions were analyzed. Thirty patients (m
Publikováno v:
European Journal of Radiology Extra. 50:21-26
We report the case of a 40-year-old woman, who had extensive hepatic necrosis, multiple liver infarctions, subcapsular liver hematoma, acute renal failure, and massive ascites in the setting of hemolysis, elevated liver enzyme levels, and a low plate
Publikováno v:
Journal of Gastroenterology. 38:796-800
We report a reactivation of hepatitis B virus infection and a severe hepatitis flare in a patient with chronic hepatitis due to dual infection with hepatitis B and C viruses during combination therapy with alpha-interferon and ribavirin. Pretreatment
Publikováno v:
European Journal of Gastroenterology & Hepatology. 15:819-823
Publikováno v:
Clinical Infectious Diseases. 36:1516-1522
We compared the use of prolonged synchronous combination therapy with interferon (IFN)-alpha-2b and lamivudine with the use of IFN-alpha-2b monotherapy in patients with untreated hepatitis B e antigen (HBeAg)-positive chronic hepatitis B virus (HBV)
Publikováno v:
Current Therapeutic Research. 63:736-747
Background: Chronic hepatitis delta virus (HDV) is a severe and rapidly progressive liver disease for which no therapy has been proved to be effective. Objective: The aim of this study was to investigate the efficacy and tolerability of long-term the
Autor:
S. Colakoglu, Hülya Çetinkaya, Atilla Ökten, Ethem Tankurt, Nurdan Tözün, Halil Degertekin, Hikmet Akkiz, Mustafa Sarioglu, Tülin Şahin, Seren Ozenirler, Hakan Bozkaya, Cihan Yurdaydin, Ozden Uzunalimoglu
Publikováno v:
Digestive Diseases and Sciences. 46:1022-1028
The contribution of hepatitis B, hepatitis C, and excess alcohol intake to the development of hepatocellular carcinoma in Turkey was assessed. The study was conducted through a questionnaire sent to seven major medical referral centers in different r
Autor:
Verena Schlaphoff, Yilmaz Cakaloglu, George N. Dalekos, Hakan Bozkaya, Kalliopi Zachou, Michael P. Manns, Stefan Zeuzem, Cihan Yurdaydin, Hans Peter Dienes, Thomas Bock, Heiner Wedemeyer, Uta Drebber, Andreas Erhardt, Halil Degertekin, Selim Gürel
Background: Hepatitis delta virus (HDV) causes severe liver disease. Aims: To investigate the quantitative HDV-RNA, HBsAg and hepatitis B virus (HBV)DNA levels in correlation to histological, biochemical and demographical parameters in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f30164ad4d2a90aba9c84d8096536f33
http://hdl.handle.net/11452/25470
http://hdl.handle.net/11452/25470
Autor:
Ozlem Erkan, Kendal Yalcin, Hayri Karaaslan, Fatih Oğuz Önder, Cihan Yurdaydin, Ozden Uzunalimoglu, Hakan Bozkaya, Halil Degertekin, A.M. Bozdayi
Publikováno v:
Journal of viral hepatitis. 14(11)
High dose interferon treatment for 1 year is the only established treatment for chronic hepatitis D, but it is associated with a high relapse rate after treatment discontinuation. In this study, patients were treated with 10 MU interferon alpha 2b, t